scispace - formally typeset
P

Pei Ming Yang

Researcher at Taipei Medical University

Publications -  76
Citations -  8398

Pei Ming Yang is an academic researcher from Taipei Medical University. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 24, co-authored 68 publications receiving 6735 citations. Previous affiliations of Pei Ming Yang include National Tsing Hua University & National Taiwan University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma

Yuan Ling Liu, +5 more
- 16 Nov 2010 - 
TL;DR: The results show that the combination of autophagy inducers with SAHA might be attractive for the treatment of HCC and pharmacological targeting of Autophagy provides promise for the management of cancer therapy.
Journal ArticleDOI

Inhibition of Autophagy Enhances Anticancer Effects of Atorvastatin in Digestive Malignancies

Pei Ming Yang, +5 more
- 01 Oct 2010 - 
TL;DR: The authors showed that atorvastatin could inhibit the growth of hepatocellular carcinoma and colorectal carcinoma (CRC) cells via induction of apoptosis.
Journal ArticleDOI

Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy.

Pei Ming Yang, +4 more
- 15 Sep 2011 - 
TL;DR: It is proposed that fisetin appears as a new potential anticancer agent which can be applied to develop a clinical protocol of human breast cancers and inhibition of autophagy by f isetin was shown as additional route to prompt anticancer activity.